Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNinety One Regulatory News (N91)

Share Price Information for Ninety One (N91)

Share Price is delayed by 15 minutes
Get Live Data
214.20    0.20 (0.09%)
Bid:
214.00
Ask:
214.20
Spread: 0.20 (0.093%)
Market Cap: £2.07b
N91 Live PriceLast checked at - London Stock Exchange

Intraday Ninety One Share Chart

Share repurchase programme

31 Mar 2025 15:30

RNS Number : 9668C
Ninety One PLC
31 March 2025
 

Ninety One plc Ninety One Limited

Incorporated in England and Wales Incorporated in the Republic of South Africa

Registration number 12245293 Registration number 2019/526481/06

Date of registration: 4 October 2019 Date of registration: 18 October 2019

LSE share code: N91 JSE share code: NY1

JSE share code: N91 ISIN: ZAE000282356

ISIN: GB00BJHPLV88

LEI: 549300G0TJCT3K15ZG14

 

 

 

Ninety One plc Repurchase of Shares

 

On 6 March 2025, Ninety One plc (the "Company") announced that it had initiated a share repurchase programme of up to £30 million (the "Programme"), beginning with an initial tranche of up to £5 million. Under the Programme, the Company's ordinary shares will be purchased in the open market and cancelled to reduce the Company's ordinary share capital.

The Company has entered into an agreement (the "Agreement") with Citigroup Global Markets Limited ("Citi") to undertake the Programme on its behalf and to make trading decisions under the Programme independently of the Company. Citi will purchase the Company's ordinary shares on the London Stock Exchange, as riskless principal, subject to certain parameters agreed between the Company and Citi, and the Company's right to terminate the Agreement in certain circumstances.

Today, the Company announces its intention to increase the initial tranche of the Programme from up to £5 million to up to £25 million and to extend the date for purchases to be completed to no later than 31 March 2026 (subject to regulatory approval remaining in place).

The purchase of ordinary shares under the Programme will be effected within the scope of any authority to repurchase ordinary shares conferred on the Company in its general meeting, the UK Market Abuse Regulation, the Companies Act 2006 and the Financial Conduct Authority's UK Listing Rules.

 

For enquiries please contact:

Investor relations

Varuni Dharma varuni.dharma@ninetyone.com +44(0) 203 938 2486

 

Date of release: 31 March 2025

JSE Sponsor: J.P. Morgan Equities South Africa (Pty) Ltd

 

About Ninety One

Ninety One is an independent investment manager, founded in South Africa in 1991. It operates and invests globally and offers a range of active strategies to its global client base. Ninety One is listed on the London and Johannesburg Stock Exchanges.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSJBMJTMTTJBLA
Date   Source Headline
1st Jul 202111:00 amRNSDirector/PDMR Shareholding
30th Jun 20212:00 pmRNSHolding(s) in Company
24th Jun 20212:00 pmRNSDirector/PDMR Shareholding
24th Jun 20212:00 pmRNSHolding(s) in Company
21st Jun 20213:00 pmRNSDirector/PDMR Shareholding
16th Jun 202110:00 amRNSAnnual Financial Report
15th Jun 20214:00 pmRNSDirectorate Change
14th Jun 20211:00 pmRNSDEALING IN SECURITIES BY EMPLOYEE BENEFIT TRUSTS
14th Jun 20211:00 pmRNSDirector/PDMR Shareholding
10th Jun 20211:00 pmRNSDEALING IN SECURITIES BY EMPLOYEE BENEFIT TRUSTS
8th Jun 20214:00 pmRNSDirector/PDMR Shareholding
8th Jun 20211:00 pmRNSDEALING IN SECURITIES BY EMPLOYEE BENEFIT TRUSTS
3rd Jun 20211:00 pmRNSHolding(s) in Company
3rd Jun 20211:00 pmRNSDirector/PDMR Shareholding
1st Jun 20211:00 pmRNSDealing in Securities by Employee Benefit Trust
1st Jun 20211:00 pmRNSDirector/PDMR Shareholding
24th May 20211:00 pmRNSDealing in Securities by Employee Benefit Trusts
19th May 20217:00 amRNSFinal Results
14th May 20219:00 amRNSDirector Declaration
29th Apr 20212:30 pmRNSDirector/PDMR Shareholding
21st Apr 202110:00 amRNSHolding(s) in Company
1st Apr 20212:30 pmRNSDirector/PDMR Shareholding
19th Mar 202112:00 pmRNSHolding(s) in Company
9th Mar 20212:30 pmRNSHolding(s) in Company
9th Mar 20212:30 pmRNSDirector/PDMR Shareholding
9th Mar 202112:00 pmRNSDirector/PDMR Shareholding
5th Mar 202112:00 pmRNSDirector/PDMR Shareholding
3rd Mar 202112:00 pmRNSDirector/PDMR Shareholding
2nd Mar 202112:00 pmRNSDirector/PDMR Shareholding
1st Mar 202112:00 pmRNSDirector/PDMR Shareholding
23rd Feb 202112:00 pmRNSDirector/PDMR Shareholding
22nd Feb 202112:00 pmRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNS3rd Quarter Update
20th Jan 202112:00 pmRNSDirector/PDMR Shareholding
19th Jan 20213:00 pmRNSDirector/PDMR Shareholding
19th Jan 202112:00 pmRNSDirector/PDMR Shareholding
18th Jan 202112:00 pmRNSDirector/PDMR Shareholding
15th Jan 202112:30 pmRNSHolding(s) in Company
15th Jan 202112:30 pmRNSDirector/PDMR Shareholding
14th Jan 202112:00 pmRNSDirector/PDMR Shareholding
13th Jan 202112:00 pmRNSDirector/PDMR Shareholding
12th Jan 20213:00 pmRNSHolding(s) in Company
12th Jan 202112:00 pmRNSDirector/PDMR Shareholding
8th Jan 202112:00 pmRNSDirector/PDMR Shareholding
7th Jan 202112:00 pmRNSDirector/PDMR Shareholding
6th Jan 202112:00 pmRNSDirector/PDMR Shareholding
5th Jan 202112:00 pmRNSDirector/PDMR Shareholding
4th Jan 20211:00 pmRNSDirector/PDMR Shareholding
24th Dec 20209:30 amRNSDirector/PDMR Shareholding
23rd Dec 202011:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.